PMID- 37240894
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230530
IS  - 2075-4426 (Print)
IS  - 2075-4426 (Electronic)
IS  - 2075-4426 (Linking)
VI  - 13
IP  - 5
DP  - 2023 Apr 25
TI  - Cardiovascular Magnetic Resonance Imaging as an Adjunct to the Evaluation of 
      Cardiovascular Involvement in Diabetes Mellitus.
LID - 10.3390/jpm13050724 [doi]
LID - 724
AB  - Diabetes mellitus (DM) is a new epidemic which has presented an immense increase 
      in recent decades, due to the rapid increase in obesity. Cardiovascular disease 
      (CVD) significantly reduces life expectancy and is the main cause of death in 
      type 2 diabetes mellitus (T2DM). Strict glycemic control is a well-established 
      method to combat microvascular CVD of type 1 diabetes mellitus (T1DM); its role 
      against CVD of the T2DM risk has not been well documented. Therefore, the most 
      efficient prevention is multifactorial risk factor reduction. Recently, the 
      European Society of Cardiology published its 2019 recommendations on CVD in DM. 
      Although all clinical points were discussed in this document, only a few comments 
      were presented about when and how we should recommend cardiovascular (CV) 
      imaging. Currently, CV imaging is the "must" in CV noninvasive evaluation. 
      Alterations in CV imaging parameters can lead to early recognition of various 
      types of CVD. In this paper, we briefly discuss the role of noninvasive imaging 
      modalities, emphasizing the benefits of including cardiovascular magnetic 
      resonance (CMR) in the evaluation of DM. CMR, in the same examination, can 
      provide an assessment of tissue characterization, perfusion and function, with 
      excellent reproducibility and without radiation or limitations, due to the body 
      habitus. Therefore, it can play a dominant role in the prevention and risk 
      stratification of DM. The suggested protocol for DM evaluation should include 
      routine annual echocardiographic evaluation of all DM patients and CMR assessment 
      of those with poorly controlled DM, microalbuminuria, heart failure, arrhythmia 
      and recent alterations in clinical or echocardiographic evaluation.
FAU - Mavrogeni, Sophie I
AU  - Mavrogeni SI
AUID- ORCID: 0000-0003-1089-7766
AD  - Onassis Cardiac Surgery Center, 17674 Athens, Greece.
AD  - University Research Institute of Maternal and Child Health and Precision 
      Medicine, Medical School, National and Kapodistrian University of Athens, Aghia 
      Sophia Children's Hospital, 11527 Athens, Greece.
AD  - Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, 
      Medical School, National and Kapodistrian University of Athens, Aghia Sophia 
      Children's Hospital, 11527 Athens, Greece.
FAU - Markousis-Mavrogenis, George
AU  - Markousis-Mavrogenis G
AUID- ORCID: 0000-0001-8192-6670
AD  - Onassis Cardiac Surgery Center, 17674 Athens, Greece.
FAU - Bacopoulou, Flora
AU  - Bacopoulou F
AUID- ORCID: 0000-0003-1001-0926
AD  - University Research Institute of Maternal and Child Health and Precision 
      Medicine, Medical School, National and Kapodistrian University of Athens, Aghia 
      Sophia Children's Hospital, 11527 Athens, Greece.
AD  - Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, 
      Medical School, National and Kapodistrian University of Athens, Aghia Sophia 
      Children's Hospital, 11527 Athens, Greece.
FAU - Chrousos, George P
AU  - Chrousos GP
AUID- ORCID: 0000-0002-3098-5264
AD  - University Research Institute of Maternal and Child Health and Precision 
      Medicine, Medical School, National and Kapodistrian University of Athens, Aghia 
      Sophia Children's Hospital, 11527 Athens, Greece.
AD  - Center for Adolescent Medicine and UNESCO Chair in Adolescent Health Care, 
      Medical School, National and Kapodistrian University of Athens, Aghia Sophia 
      Children's Hospital, 11527 Athens, Greece.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230425
PL  - Switzerland
TA  - J Pers Med
JT  - Journal of personalized medicine
JID - 101602269
PMC - PMC10222166
OTO - NOTNLM
OT  - cardiovascular
OT  - cardiovascular magnetic resonance
OT  - diabetes mellitus
OT  - imaging
COIS- The authors declare no conflict of interest.
EDAT- 2023/05/27 09:42
MHDA- 2023/05/27 09:43
PMCR- 2023/04/25
CRDT- 2023/05/27 01:19
PHST- 2023/03/14 00:00 [received]
PHST- 2023/04/13 00:00 [revised]
PHST- 2023/04/22 00:00 [accepted]
PHST- 2023/05/27 09:43 [medline]
PHST- 2023/05/27 09:42 [pubmed]
PHST- 2023/05/27 01:19 [entrez]
PHST- 2023/04/25 00:00 [pmc-release]
AID - jpm13050724 [pii]
AID - jpm-13-00724 [pii]
AID - 10.3390/jpm13050724 [doi]
PST - epublish
SO  - J Pers Med. 2023 Apr 25;13(5):724. doi: 10.3390/jpm13050724.